Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment.
about
Treating depression within the HIV "medical home": a guided algorithm for antidepressant management by HIV cliniciansFuture directions for interventions targeting PTSD in HIV-infected adultsRelationship between food insecurity and mortality among HIV-positive injection drug users receiving antiretroviral therapy in British Columbia, CanadaModerate levels of depression predict sexual transmission risk in HIV-infected MSM: a longitudinal analysis of data from six sites involved in a "prevention for positives" studyDepressive symptoms, HIV medication adherence, and HIV clinical outcomes in Tanzania: a prospective, observational study.Critical consciousness, racial and gender discrimination, and HIV disease markers in African American women with HIV.Common mental disorders in TB/HIV co-infected patients in Ethiopia.A multilevel mediation model of stress and coping for women with HIV and their families.Stressful life events and their relationship to psychological and medical functioning in children and adolescents with HIV infection.Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the Nutrition for Healthy Living study.Antiretroviral treatment adherence as a mediating factor between psychosocial variables and HIV viral load.Perceived stress and norepinephrine predict the effectiveness of response to protease inhibitors in HIV.Dispositional optimism and the mechanisms by which it predicts slower disease progression in HIV: proactive behavior, avoidant coping, and depressionPersons newly diagnosed with HIV infection are at high risk for depression and poor linkage to care: results from the Steps Study.Mindfulness meditation training effects on CD4+ T lymphocytes in HIV-1 infected adults: a small randomized controlled trial.Effect of stress and depression on the frequency of squamous intraepithelial lesions.Stress buffering effects of oxytocin on HIV status in low-income ethnic minority womenPredicting virologic failure in an HIV clinic.ACT HEALTHY: A Combined Cognitive-Behavioral Depression and Medication Adherence Treatment for HIV-Infected Substance Users.Prevalence of Psychiatric and Substance Abuse Symptomatology Among HIV-Infected Gay and Bisexual Men in HIV Primary Care.Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis.A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIVConceptual framework for understanding the bidirectional links between food insecurity and HIV/AIDS.Young adults' experiences with cancer: comments from patients and survivors.Gender-specific effects of an augmented written emotional disclosure intervention on posttraumatic, depressive, and HIV-disease-related outcomes: a randomized, controlled trialPsychosocial and Neurohormonal Predictors of HIV Disease Progression (CD4 Cells and Viral Load): A 4 Year Prospective StudyPredictors of disease progression in HIV infection: a review.'I was thinking too much': experiences of HIV-positive adults with common mental disorders and poor adherence to antiretroviral therapy in Zimbabwe.An increase in religiousness/spirituality occurs after HIV diagnosis and predicts slower disease progression over 4 years in people with HIV.Associations among depression, suicidal behavior, and quality of life in patients with human immunodeficiency virus.Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trialAssociation of individual and systemic barriers to optimal medical care in people living with HIV/AIDS in Miami-Dade County.Disparities in Depressive Symptoms and Antidepressant Treatment by Gender and Race/Ethnicity among People Living with HIV in the United StatesPain, mood, and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failureThe effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trialIdentifying HIV-Infected Women's Psychosocial Stressors: Findings from a Qualitative Study.The effect of relaxation interventions on cortisol levels in HIV-seropositive womenEffects of syndemics on HIV viral load and medication adherence in the multicentre AIDS cohort studyProspective prediction of viral suppression and immune response nine months after ART initiation in Seattle, WA.Poor CD4 count is a predictor of untreated depression in human immunodeficiency virus-positive African-Americans.
P2860
Q26823842-E1FD5409-E94C-4888-ABCE-59E62442D647Q28083772-A666CC17-7EDD-4BA0-B603-C85EC3656BFBQ28533313-1F8BF15F-87AC-40E5-A164-C26C4E87BC22Q30619310-E2CCED7E-A4EF-40EA-B903-3483C7C93B6FQ33567697-D63A7CFF-4B26-4A25-B50D-E267C015C310Q33568220-61176499-39DF-4FA4-82E7-E3FD2D83206BQ33629420-4BD23568-C196-4F92-835A-CB64D8BA4B9DQ33631272-1619D29B-FC89-4F8D-9002-7ED31E3C0C50Q33636117-EBB56F06-2EC5-4101-A9E7-22F5B0DB2CC3Q33879163-757896D4-7CBA-45D8-A492-A0A26843AEB4Q34324910-519E0984-F050-42B4-BC41-43962D0E111BQ34400028-FAE435A7-7063-4F74-9228-839F3B3D37A2Q34400036-389518B0-69C5-432F-B718-4FA0DE5D0C8BQ34532722-41CD37F6-6FF8-4A29-A170-25CAE728F85FQ34595114-EDF6C17E-9635-4CC9-AAF5-8152030F6440Q34888045-2B5CC7C3-5B8A-45A8-B1C9-773F1217E58FQ34982148-52ED6137-1C44-4174-98BC-48643D0A497EQ35006362-0BE80240-AFFD-4CC4-B7A1-0C00FA070CCFQ35067321-94FD9314-D738-42E1-9A1D-447CCC37F9F7Q35118922-C705C768-9B9B-4D31-A738-8C6ED8CDE0FFQ35177350-AFC70157-BB21-4CBD-9B57-D7B8EF1726A1Q35526694-9D15DEAA-7AA1-44F9-BAB4-E4BE4722A259Q35578711-9D3F57D4-7B49-41B5-88E3-9BB475BFECD8Q35613166-19620BE6-41FE-4D50-A0D2-5C7924340383Q35735185-3A458512-260C-46D4-A7E8-E0861E0AB306Q35736120-2A853D98-2496-4D18-9D6F-086A41B65D4AQ35834337-668AF46F-34CD-4C11-8BF2-41EA787767E8Q35847744-4D6D225D-832E-427F-AA34-40EE019AA81BQ35901754-9F912013-1D76-4FA0-ADCC-E33F329E7455Q35947922-7D26C65E-1CB3-4CEE-B9B6-3067224EC636Q36002565-4E0B3EC9-37F6-4C89-9E6A-55C23E3FA776Q36028304-9DA8F4A1-6EEC-4415-B572-7701E1358209Q36101101-5C599C83-C616-48B9-A8F3-85B27A85568CQ36282679-0A31596A-254A-4B72-A091-5A7BD4B45995Q36345563-DEA1C8BD-19F8-4139-A059-3AB79A501034Q36514709-AF36985C-0A24-4E98-BE48-73808A159D41Q36515224-C403FFBC-7F9D-4B1F-9492-DA20FE3CE6F9Q36539335-EC97FE01-8636-4A11-896C-04251F2ADC6CQ36644290-E7604689-F52B-4B5F-9404-76AA23F6FBBAQ36719404-3AFC7F43-0A81-45E8-8020-6EF2A7689EED
P2860
Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Psychosocial factors predict C ...... tive antiretroviral treatment.
@en
Psychosocial factors predict C ...... tive antiretroviral treatment.
@nl
type
label
Psychosocial factors predict C ...... tive antiretroviral treatment.
@en
Psychosocial factors predict C ...... tive antiretroviral treatment.
@nl
prefLabel
Psychosocial factors predict C ...... tive antiretroviral treatment.
@en
Psychosocial factors predict C ...... tive antiretroviral treatment.
@nl
P2093
P2860
P921
P1476
Psychosocial factors predict C ...... tive antiretroviral treatment.
@en
P2093
Conall O'Cleirigh
Elizabeth Balbin
George Solomon
Jean Philippe Laurenceau
Mary Ann Fletcher
Neil Schneiderman
P2860
P304
P356
10.1097/01.PSY.0000188569.58998.C8
P407
P577
2005-11-01T00:00:00Z